Impax Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Impax Asset Management's LLY Position: Q2 2018 in Review
Impax Asset Management increased its Eli Lilly (LLY) stake by 1,594% in Q2 2018, buying an estimated $13.9M and bringing the position to 179,713 shares worth $15.3M. The position accounts for 0.91% of the portfolio, ranked #43.
Impax Asset Management first reported a position in LLY in Q3 2014 and has held it in 16 quarters since. 1,369 funds tracked by Wall St. Rank hold LLY as of Q2 2018.
- Impax Asset Management held 179,713 shares of Eli Lilly worth $15.3M as of Q2 2018.
- Impax Asset Management bought 169,106 Eli Lilly shares in Q2 2018, an estimated $13.9M.
- Eli Lilly made up 0.91% of Impax Asset Management's portfolio in Q2 2018, its #43 holding.
- Impax Asset Management first reported a position in Eli Lilly in Q3 2014 and has held it in 16 quarters since.
- 1,369 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2018.
Based on Impax Asset Management's 13F filing for Q2 2018, filed 14 Aug 2018.